Anti-Human RNASE3 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22073; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-Human RNASE3 Polyclonal Antibody – a reliable and high-quality tool for your biotech research needs.
This antibody is specifically designed to target the human RNASE3 protein, also known as eosinophil cationic protein (ECP). RNASE3 is a member of the ribonuclease A superfamily and is primarily expressed in eosinophils, a type of white blood cell involved in the immune response.
The biological function of RNASE3 is to degrade RNA, making it an essential enzyme in various cellular processes. However, elevated levels of RNASE3 have been linked to several diseases, including asthma, allergic rhinitis, and certain cancers. Therefore, our Anti-Human RNASE3 Polyclonal Antibody is a valuable tool for studying the role of RNASE3 in these conditions.
This antibody has a wide range of applications in biotech research, including Western blotting, immunohistochemistry, and ELISA. It has been validated for use in human samples, ensuring accurate and reliable results.
Our Anti-Human RNASE3 Polyclonal Antibody has been extensively tested and proven to provide excellent sensitivity and specificity. It has a high affinity for its target protein, allowing for efficient detection and quantification.
In addition to its traditional applications, this antibody has also been successfully used in various experimental settings. For example, it has been used to study the expression and localization of RNASE3 in different tissues and cell types. It has also been used to investigate the effects of RNASE3 inhibitors and activators on cellular function.
With its versatile applications and reliable performance, our Anti-Human RNASE3 Polyclonal Antibody is an essential tool for any biotech researcher interested in studying the role of RNASE3 in human health and disease. Don’t miss out on the opportunity to enhance your research with this high-quality antibody. Order now and take your studies to the next level!
ProteoGenix catalogue number ARO-A22073. For research use only.
Target: Eosinophil cationic protein; ECP; 3.1.27.-; Ribonuclease 3; RNase 3; RNASE3; ECP; RNS3; Clonality: Polyclonal Antibody; Reactivity: Human; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
